Literature DB >> 7819583

Tumor suppressor genes and their roles in breast cancer.

L A Cox1, G Chen, E Y Lee.   

Abstract

Tumor suppressor genes have been identified by the occurrence of mutations in many families with hereditary forms of cancer, exposed during development of the tumor by loss of heterozygosity. They have a number of diverse functions. For example, both the RB gene of retinoblastoma and the p53 gene, which is commonly mutated in breast and colon cancer among others, produce proteins involved in distinct steps of cell cycle control, while the nm23 product prevents metastasis. Here we review the data developed until now on the possible presence and role of mutations in these and other tumor suppressor genes in breast cancer. A more complete understanding of the tumor suppressor genes could not only provide diagnostic information, but could lead to specific gene therapy to replace suppressor functions lost in individual tumors.

Entities:  

Mesh:

Year:  1994        PMID: 7819583     DOI: 10.1007/bf00666203

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  213 in total

1.  Accumulation of genetic alterations and progression of primary breast cancer.

Authors:  T Sato; F Akiyama; G Sakamoto; F Kasumi; Y Nakamura
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

2.  Pediatric molecular oncology. Past as prologue to the future.

Authors:  A G Knudson
Journal:  Cancer       Date:  1993-05-15       Impact factor: 6.860

3.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

4.  Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.

Authors:  T I Andersen; A Gaustad; L Ottestad; G W Farrants; J M Nesland; K M Tveit; A L Børresen
Journal:  Genes Chromosomes Cancer       Date:  1992-03       Impact factor: 5.006

Review 5.  A comparison of the biological activities of wild-type and mutant p53.

Authors:  G P Zambetti; A J Levine
Journal:  FASEB J       Date:  1993-07       Impact factor: 5.191

6.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product.

Authors:  A K Rustgi; N Dyson; R Bernards
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle.

Authors:  E Wagner; C Plank; K Zatloukal; M Cotten; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

10.  The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.

Authors:  J A Lees; K J Buchkovich; D R Marshak; C W Anderson; E Harlow
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  9 in total

1.  Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progression.

Authors:  G Wani; I Noyes; G E Milo; S M D'Ambrosio
Journal:  Mol Med       Date:  1997-04       Impact factor: 6.354

2.  Growth inhibitory efficacy of Cornus officinalis in a cell culture model for triple-negative breast cancer.

Authors:  Nitin T Telang; Hareesh B Nair; George Y C Wong
Journal:  Oncol Lett       Date:  2019-03-21       Impact factor: 2.967

Review 3.  Molecular pathology of tumor metastasis. I. Predictive pathology.

Authors:  J Tímár; O Csuka; Z Orosz; A Jeney; L Kopper
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

4.  Growth inhibitory efficacy of natural products in a model for triple negative molecular subtype of clinical breast cancer.

Authors:  Nitin Telang
Journal:  Biomed Rep       Date:  2017-08-01

Review 5.  The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.

Authors:  O V Volpert; V Stellmach; N Bouck
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

6.  Raf-1 physically interacts with Rb and regulates its function: a link between mitogenic signaling and cell cycle regulation.

Authors:  S Wang; R N Ghosh; S P Chellappan
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

Review 7.  Gene therapy for carcinoma of the breast: Genetic ablation strategies.

Authors:  D T Curiel
Journal:  Breast Cancer Res       Date:  1999-12-17       Impact factor: 6.466

8.  Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q.

Authors:  A Schwendel; F Richard; H Langreck; O Kaufmann; H Lage; K J Winzer; I Petersen; M Dietel
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

Review 9.  Growth Inhibitory Efficacy of Chinese Herbs in a Cellular Model for Triple-Negative Breast Cancer.

Authors:  Nitin T Telang; Hareesh B Nair; George Y C Wong
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.